Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis Reply

被引：115
作者：
Sandborn, William J. [1 ]
Su, Chinyu [2 ]
Panes, Julian [3 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Pfizer, Collegeville, PA USA
[3] Hosp Clin Barcelona, Barcelona, Spain
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 377卷 / 05期
关键词：
D O I：
10.1056/NEJMc1707500
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：496 / 497
页数：2
相关论文
共 5 条
[1]   Tofacitinib for Induction Therapy in Patients with Active Ulcerative Colitis in Two Phase 3 Clinical Trials: Results by Local and Central Endoscopic Assessments [J].
Feagan, Brian ;
Vermeire, Severine ;
Sandborn, William J. ;
Reinisch, Walter ;
Tarabar, Dino ;
Su, Chinyu ;
Niezychowski, Wojciech ;
Zhang, Haiying ;
Woodworth, Deborah ;
Yu, Dahong ;
Sands, Bruce .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 :S319-S320
[2]   Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis [J].
Feagan, Brian G. ;
Rutgeerts, Paul ;
Sands, Bruce E. ;
Hanauer, Stephen ;
Colombel, Jean-Frederic ;
Sandborn, William J. ;
Van Assche, Gert ;
Axler, Jeffrey ;
Kim, Hyo-Jong ;
Danese, Silvio ;
Fox, Irving ;
Milch, Catherine ;
Sankoh, Serap ;
Wyant, Tim ;
Xu, Jing ;
Parikh, Asit .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) :699-710
[3]   Why interleukin-10 supplementation does not work in Crohn's disease patients [J].
Marlow, Gareth J. ;
van Gent, Dominique ;
Ferguson, Lynnette R. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (25) :3931-3941
[4]   Therapeutic opportunities of the IL-22-IL-22R1 system [J].
Sabat, Robert ;
Ouyang, Wenjun ;
Wolk, Kerstin .
NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (01) :21-38
[5]   Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis [J].
Sandborn, William J. ;
van Assche, Gert ;
Reinisch, Walter ;
Colombel, Jean-Frederic ;
D'Haens, Geert ;
Wolf, Douglas C. ;
Kron, Martina ;
Tighe, Mary Beth ;
Lazar, Andreas ;
Thakkar, Roopal B. .
GASTROENTEROLOGY, 2012, 142 (02) :257-+
1